Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Baudax Bio Inc | BXRX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.1864 | 18:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1864 | 0.1864 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.149 - 6.89 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.1864 | USD |
Baudax Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.28M | 43.59M | - | 1.27M | -58.8M | -1.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Baudax Bio News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/15/2023 | 16:25 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 11/15/2023 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/25/2023 | 06:57 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/13/2023 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/11/2023 | 15:47 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 10/10/2023 | 06:00 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 10/06/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/29/2023 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/25/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 9/21/2023 | 16:30 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 9/21/2023 | 15:48 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of.. |
| 9/07/2023 | 16:16 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BXRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.205 | 0.25 | 0.160401 | 0.2030001 | 370,952 | -0.0186 | -9.07% |
| 3 Months | 0.39 | 0.78 | 0.149 | 0.3949351 | 4,762,599 | -0.2036 | -52.21% |
| 6 Months | 0.51 | 1.4299 | 0.149 | 0.6590399 | 3,172,075 | -0.3236 | -63.45% |
| 1 Year | 5.83 | 6.89 | 0.149 | 1.57 | 2,391,329 | -5.64 | -96.8% |
| 3 Years | 48.00 | 234.00 | 0.149 | 23.95 | 2,435,167 | -47.81 | -99.61% |
| 5 Years | 143.20 | 467.60 | 0.149 | 34.42 | 1,989,954 | -143.01 | -99.87% |
Baudax Bio Description
| Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. |
